Joseph P. St. Laurent,Gerald S. Jones,David M. Bresse
申请号:
US14562608
公开号:
US09205067B2
申请日:
2014.12.05
申请国别(地区):
US
年份:
2015
代理人:
摘要:
The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and ω-(methylsulfonyl)alkylamine or ω-(methylsulfonyl)alkylamide. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering ω-(methylsulfonyl)alkylamine or ω-(methylsulfonyl)alkylamide, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof.